Description

Androfarm (cyproterone) 100 mg/ml. 3 ml. ampoules N3

Ingredients

Active ingredient: Cyproterone acetate

Dosage

Dosage: The usual dose is 100 mg daily for 10 to 20 days per cycle.

Indications

Indications: Androfarm is indicated for the treatment of hirsutism in women of reproductive age.

Contraindications

Contraindications: Do not use Androfarm if you have liver problems or are pregnant.

Directions

Directions: Androfarm is administered by intramuscular injection. Follow the instructions provided by your healthcare provider.

Scientific Evidence

Androfarm containing cyproterone acetate has been shown in studies to effectively reduce hirsutism in women by blocking the androgen receptors and inhibiting the production of androgens. Research published in the Journal of Clinical Endocrinology & Metabolism demonstrated a significant improvement in hirsutism scores after treatment with cyproterone acetate.

Additional Information

It is important to note that Androfarm should be used under the supervision of a healthcare provider due to its potential side effects and interactions with other medications. Regular monitoring of liver function tests is recommended during treatment with Androfarm.

Pharmacological Effects

Cyproterone acetate, the active ingredient in Androfarm, acts as an anti-androgen by competitively blocking the binding of dihydrotestosterone to its receptors. This results in a reduction of androgenic symptoms such as hirsutism. Additionally, cyproterone acetate has progestational activity, making it useful in hormone-related conditions.

Clinical Trials and Comparative Effectiveness

In a comparative study published in the European Journal of Endocrinology, cyproterone acetate was found to be more effective in reducing hirsutism compared to spironolactone, another commonly used anti-androgen. The study highlighted the superior efficacy of cyproterone acetate in improving hirsutism scores and quality of life in women with hyperandrogenism.

• Cyproterone acetate in Androfarm has shown promising results in clinical trials for the treatment of hirsutism.
• Research suggests that cyproterone acetate is more effective than some alternative treatments for hirsutism.